146 related articles for article (PubMed ID: 12795782)
1. (R,S)-salbutamol plasma concentrations in severe asthma.
Jacobson GA; Chong FV; Wood-Baker R
J Clin Pharm Ther; 2003 Jun; 28(3):235-8. PubMed ID: 12795782
[TBL] [Abstract][Full Text] [Related]
2. Preserved bronchial dilatation after salbutamol does not guarantee protection against bronchial hyperresponsiveness.
Sjöswärd KN; Josefsson M; Ahlner J; Schmekel B
Clin Physiol Funct Imaging; 2003 Jan; 23(1):14-20. PubMed ID: 12558609
[TBL] [Abstract][Full Text] [Related]
3. SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels?
Jacobson GA; Yee KC; Wood-Baker R; Walters EH
Drug Test Anal; 2015 Feb; 7(2):109-13. PubMed ID: 24692077
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
Lipworth BJ; Clark DJ; Koch P; Arbeeny C
Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of levosalbutamol: what are the clinical implications?
Boulton DW; Fawcett JP
Clin Pharmacokinet; 2001 Jan; 40(1):23-40. PubMed ID: 11236808
[TBL] [Abstract][Full Text] [Related]
6. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine.
Cockcroft DW; Swystun VA
Thorax; 1997 Oct; 52(10):845-8. PubMed ID: 9404369
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?
Rotta ET; Amantéa SL; Froehlich PE; Becker A
Eur J Clin Pharmacol; 2010 Jun; 66(6):605-10. PubMed ID: 20195589
[TBL] [Abstract][Full Text] [Related]
9. Effects of airway calibre on lung delivery of nebulised salbutamol.
Lipworth BJ; Clark DJ
Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
[TBL] [Abstract][Full Text] [Related]
10. Bronchopulmonary pharmacokinetics of (R)-salbutamol and (S)-salbutamol enantiomers in pulmonary epithelial lining fluid and lung tissue of horses.
Jacobson GA; Raidal S; Robson K; Narkowicz CK; Nichols DS; Haydn Walters E
Br J Clin Pharmacol; 2017 Jul; 83(7):1436-1445. PubMed ID: 28061018
[TBL] [Abstract][Full Text] [Related]
11. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer.
Rodrigo C; Rodrigo G
Am J Emerg Med; 1998 Nov; 16(7):637-42. PubMed ID: 9827736
[TBL] [Abstract][Full Text] [Related]
12. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
Patel M; Thomson NC
Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221
[TBL] [Abstract][Full Text] [Related]
13. Levosalbutamol in the treatment of asthma.
Milgrom H
Expert Opin Pharmacother; 2006 Aug; 7(12):1659-68. PubMed ID: 16872269
[TBL] [Abstract][Full Text] [Related]
14. Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma.
Ramsay CM; Cowan J; Flannery E; McLachlan C; Taylor DR
Eur J Clin Pharmacol; 1999 Jul; 55(5):353-9. PubMed ID: 10456484
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
Pulm Pharmacol Ther; 1999; 12(6):353-62. PubMed ID: 10587476
[TBL] [Abstract][Full Text] [Related]
16. Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma.
Memon BN; Parkash A; Ahmed Khan KM; Gowa MA; Bai C
J Pak Med Assoc; 2016 Mar; 66(3):243-6. PubMed ID: 26968269
[TBL] [Abstract][Full Text] [Related]
17. Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle.
Jacobson GA; Yee KC; Premilovac D; Rattigan S
Drug Test Anal; 2014 Jun; 6(6):563-7. PubMed ID: 24574331
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi.
Matera MG; Calzetta L; Rogliani P; Bardaro F; Page CP; Cazzola M
Pulm Pharmacol Ther; 2011 Apr; 24(2):221-6. PubMed ID: 21195788
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
Gawchik SM; Saccar CL; Noonan M; Reasner DS; DeGraw SS
J Allergy Clin Immunol; 1999 Apr; 103(4):615-21. PubMed ID: 10200010
[TBL] [Abstract][Full Text] [Related]
20. Investigation of urinary levels of salbutamol in asthmatic patients receiving inhaled therapy.
Jacobson GA; Peterson GM; McLean S
J Clin Pharm Ther; 1997 Apr; 22(2):119-26. PubMed ID: 9373810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
